Skip to content

Study of the Effect of Vagus Nerve Stimulation on Human Brown Adipose Tissue Activity

Brown Adipose Tissue After Vagus Nerve Stimulation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01491282
Enrollment
5
Registered
2011-12-13
Start date
2011-01-31
Completion date
2012-11-30
Last updated
2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

human brown adipose tissue activity, obesity, energy metabolism, adaptive thermogenesis

Brief summary

To evaluate the effect of vagus nerve stimulation for refractory epilepsy on the activity of human brown adipose tissue.

Interventions

OTHEREnabling and disabling VNS

No intervention

Sponsors

Maastricht University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Subjects treated with VNS for epilepsy, aged 18-65 years, with a Body Mass Index (BMI) ≤ 28 kg/m2.

Exclusion criteria

* Body Mass Index \> 28 kg/m2 * Daily epileptic insults. * Subjects that need 'Rapid Cycling' VNS to control their frequency of epileptic insults. * Psychological unstable subjects (as judged by the treating neurologist). * subjects with mental retardation (as judged by the treating neurologist). * subjects with severe behaviour disorders (as judged by the treating neurologist). * Pregnant subjects. * Subjects that previously underwent high dose radiation for diagnostic or therapeutic purposes (radiotherapy, high frequency CT-scans). * The use of the following medication is an exclusion criterium; * ß-blockers, * Ketogenic diet

Design outcomes

Primary

MeasureTime frame
human brown adipose tissue activitybaseline and 2 weeks after

Countries

Netherlands

Contacts

Primary ContactGuy H. Vijgen, M.D.
G.vijgen@maastrichtuniversity.nl+31618942736
Backup ContactWouter D. van Marken Lichtenbelt, PhD.
markenlichtenbelt@maastrichtuniversity.nl+31433881629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026